| |
|
|
|
Ampio Pharmaceuticals  
|
|
1.36 -0.02 (-0.01%) |
01-15 16:00 |
|
Open: |
1.36 |
Pre close: |
1.38 |
Target:
|
2.66
|
|
High: |
1.4 |
Low: |
1.29 |
Resistance:
|
2.28
2.98
|
|
Volume: |
4,440,482 |
Market Cap: |
252M |
Support:
|
1.15
0.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.42
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
1.71 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
1.06  |
Stochastic Oscillator |
%K(14,3):
|
3.98 |
|
MA(250): |
0.80 |
%D(3): |
4.60 |
|
Average Volume(K) |
3-Month: |
587092
|
52-Week |
High:
|
2.98 |
|
10-Days: |
388384 |
Low: |
0.31 |
|
RSI |
RSI(14):
|
46.24 |
Change(%): |
103.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.131 |
Return on Equity (ttm) |
-185.1 |
Shares Out. (M) |
176.54 |
|
EPS Est. Current Year |
-0.610 |
Return on Assets (ttm) |
-79.9 |
Shares Float (M) |
161.18 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.65 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.07 |
|
Forward EPS |
0.460 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
16000 |
|
Book Value (p.s.) |
0.040 |
EBITDA (p.s.) |
-0.112 |
P/E |
-10.38 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
34.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.63 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.25 |
P/CF |
-12.89 |
|
|
|
|
|
|
